HR6089Referred to Committee

Biomanufacturing Excellence Act of 2025

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-11-18
Introduced
16
Cosponsors
HR
ⓘ
Type

Sponsor

Chrissy Houlahan
Chrissy Houlahan
Democrat · PA · Representative
Votes with party: 95.4% (647 recorded votes)
Top industries funding sponsor:
  • Climate & Environment$1k

Full profile: /officials/H001085

Source: Congress.gov · FEC

Cosponsors (16)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the House Committee on Science, Space, and Technology.

2025-11-18

Source: Congress.gov

Committee Activity

Currently in

Previously

Plain-English Summary

This bill aims to strengthen the United States' ability to manufacture biological products like vaccines, medicines, and cell therapies by investing in research, facilities, and workforce training. It would help American companies compete globally in the growing biomanufacturing industry while reducing dependence on other countries for critical health products. The legislation affects pharmaceutical companies, research institutions, workers entering the biotech field, and ultimately patients who rely on these medicines.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Science, Technology, Communications
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.